Literature DB >> 20829824

Global health or global wealth?

Rahim Rezaie1, Peter A Singer.   

Abstract

Mesh：

Year:  2010        PMID： 20829824     DOI： 10.1038/nbt0910-907

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  12 in total

1.  Advance price or purchase commitments to create markets for treatments for diseases of poverty: lessons from three policies.

Authors:  Adrian Towse; Hannah Kettler
Journal:  Bull World Health Organ       Date:  2005-04-25       Impact factor: 9.408

2.  Encouraging the development of new vaccines.

Authors:  Henry Grabowski
Journal:  Health Aff (Millwood)       Date:  2005 May-Jun       Impact factor: 6.301

3.  Grand challenges in chronic non-communicable diseases.

Authors:  Abdallah S Daar; Peter A Singer; Deepa Leah Persad; Stig K Pramming; David R Matthews; Robert Beaglehole; Alan Bernstein; Leszek K Borysiewicz; Stephen Colagiuri; Nirmal Ganguly; Roger I Glass; Diane T Finegood; Jeffrey Koplan; Elizabeth G Nabel; George Sarna; Nizal Sarrafzadegan; Richard Smith; Derek Yach; John Bell
Journal:  Nature       Date:  2007-11-22       Impact factor: 49.962

4.  Developing drugs for developing countries.

Authors:  David B Ridley; Henry G Grabowski; Jeffrey L Moe
Journal:  Health Aff (Millwood)       Date:  2006 Mar-Apr       Impact factor: 6.301

5.  India's health biotech sector at a crossroads.

Authors:  Sarah E Frew; Rahim Rezaie; Stephen M Sammut; Monali Ray; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2007-04       Impact factor: 54.908

6.  Small but tenacious: South Africa's health biotech sector.

Authors:  Sara Al-Bader; Sarah E Frew; Insiya Essajee; Victor Y Liu; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2009-05       Impact factor: 54.908

Review 7.  Brazilian health biotech--fostering crosstalk between public and private sectors.

Authors:  Rahim Rezaie; Sarah E Frew; Stephen M Sammut; Maya R Maliakkal; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2008-06       Impact factor: 54.908

8.  A business plan to help the 'global South' in its fight against neglected diseases.

Authors:  Sarah E Frew; Victor Y Liu; Peter A Singer
Journal:  Health Aff (Millwood)       Date:  2009 Nov-Dec       Impact factor: 6.301

9.  Progress in public-private partnerships to fight neglected diseases.

Authors:  Kenneth Gustavsen; Christy Hanson
Journal:  Health Aff (Millwood)       Date:  2009 Nov-Dec       Impact factor: 6.301

Review 10.  Chinese health biotech and the billion-patient market.

Authors:  Sarah E Frew; Stephen M Sammut; Alysha F Shore; Joshua K Ramjist; Sara Al-Bader; Rahim Rezaie; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2008-01       Impact factor: 54.908
View more
  4 in total

Review 1.  World health dilemmas: Orphan and rare diseases, orphan drugs and orphan patients.

Authors:  Christina N Kontoghiorghe; Nicholas Andreou; Katerina Constantinou; George J Kontoghiorghes
Journal:  World J Methodol       Date:  2014-09-26

2.  Emergence of biopharmaceutical innovators in China, India, Brazil, and South Africa as global competitors and collaborators.

Authors:  Rahim Rezaie; Anita M McGahan; Sarah E Frew; Abdallah S Daar; Peter A Singer
Journal:  Health Res Policy Syst       Date:  2012-06-06

3.  Indian vaccine innovation: the case of Shantha Biotechnics.

Authors:  Justin Chakma; Hassan Masum; Kumar Perampaladas; Jennifer Heys; Peter A Singer
Journal:  Global Health       Date:  2011-04-20       Impact factor: 4.185

4.  Obstacles and opportunities in Chinese pharmaceutical innovation.

Authors:  Jingyun Ni; Junrui Zhao; Carolina Oi Lam Ung; Yuanjia Hu; Hao Hu; Yitao Wang
Journal:  Global Health       Date:  2017-03-24       Impact factor: 4.185
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.